Usual Adult Dose for Meningococcal Meningitis Prophylaxis
0.5 mL intramuscularly once
Usual Pediatric Dose for Meningococcal Meningitis Prophylaxis
2 years or older:
0.5 mL intramuscularly once.
Renal Dose Adjustments
Data not available
Liver Dose Adjustments
Data not available
Dose Adjustments
Revaccination:
Booster doses of 0.5 mL, subcutaneously, may be given to patients at high risk for meningococcal disease.
The ACIP (Advisory Committee on Immunization Practices) has revaccination recommendations.
Precautions
CONTRAINDICATIONS:
Severe allergic reaction (e.g. anaphylaxis) to any of the ingredients or to other CRM197-, diphtheria toxoid-, or meningococcal-containing vaccine
Safety and efficacy have not been established in patients younger than 2 years.
To report suspected adverse reactions, contact the Vaccine Adverse Event Reporting System (VAERS) at: https://vaers.hhs.gov
Consult WARNINGS section for additional precautions.
